| Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B JP Villeneuve, LD Condreay, B Willems, G Pomier‐Layrargues, ... Hepatology 31 (1), 207-210, 2000 | 807 | 2000 |
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ... Journal of viral hepatitis 21, 34-59, 2014 | 562 | 2014 |
| Historical epidemiology of hepatitis C virus (HCV) in selected countries P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ... Journal of viral hepatitis 21, 5-33, 2014 | 416 | 2014 |
| The mitogen-activated protein kinase kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G1 phase … H Talarmin, C Rescan, S Cariou, D Glaise, G Zanninelli, M Bilodeau, ... Molecular and cellular biology 19 (9), 6003-6011, 1999 | 330 | 1999 |
| Strategies to manage hepatitis C virus (HCV) disease burden H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ... Journal of viral hepatitis 21, 60-89, 2014 | 278 | 2014 |
| Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro: evidence of a mitogen restriction point in mid-late G1 P Loyer, S Cariou, D Glaise, M Bilodeau, G Baffet, C Guguen-Guillouzo Journal of Biological Chemistry 271 (19), 11484-11492, 1996 | 268 | 1996 |
| Variability in hepatic iron concentration measurement from needle-biopsy specimens JP Villeneuve, M Bilodeau, R Lepage, J Côté, M Lefebvre Journal of hepatology 25 (2), 172-177, 1996 | 265 | 1996 |
| Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease I Pache, M Bilodeau Alimentary pharmacology & therapeutics 21 (5), 525-529, 2005 | 237 | 2005 |
| Burden of disease and cost of chronic hepatitis C virus infection in Canada RP Myers, M Krajden, M Bilodeau, K Kaita, P Marotta, K Peltekian, ... Canadian Journal of Gastroenterology and Hepatology 28 (5), 243-250, 2014 | 213 | 2014 |
| Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial G Pomier-Layrargues, JP Villeneuve, M Deschenes, B Bui, P Perreault, ... Gut 48 (3), 390-396, 2001 | 203 | 2001 |
| Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin CJ Miranda, H Makui, RJ Soares, M Bilodeau, J Mui, H Vali, R Bertrand, ... Blood 102 (7), 2574-2580, 2003 | 192 | 2003 |
| Sinusoidal endothelial cell and hepatocyte death following cold ischemia‐warm reperfusion of the rat liver PM Huet, MR Nagaoka, G Desbiens, E Tarrab, A Brault, MP Bralet, ... Hepatology 39 (4), 1110-1119, 2004 | 179 | 2004 |
| The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver H Shah, M Bilodeau, KW Burak, C Cooper, M Klein, A Ramji, D Smyth, ... Cmaj 190 (22), E677-E687, 2018 | 158 | 2018 |
| Type 3 cytokines IL-17A and IL-22 drive TGF-β–dependent liver fibrosis T Fabre, MF Molina, G Soucy, JP Goulet, B Willems, JP Villeneuve, ... Science immunology 3 (28), eaar7754, 2018 | 148 | 2018 |
| Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β KM Hart, T Fabre, JC Sciurba, RL Gieseck III, LA Borthwick, KM Vannella, ... Science translational medicine 9 (396), eaal3694, 2017 | 140 | 2017 |
| Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study A Tran, JP Villeneuve, M Bilodeau, B Willems, D Marleau, D Fenyves, ... The American journal of gastroenterology 94 (10), 2909-2911, 1999 | 138 | 1999 |
| Hepatic artery buffer response following left portal vein ligation: its role in liver tissue homeostasis B Rocheleau, C Ethier, R Houle, PM Huet, M Bilodeau American Journal of Physiology-Gastrointestinal and Liver Physiology 277 (5 …, 1999 | 132 | 1999 |
| Metabolic insights into the hepatoprotective role of N‐acetylcysteine in mouse liver C Zwingmann, M Bilodeau Hepatology 43 (3), 454-463, 2006 | 118 | 2006 |
| An update on the management of chronic hepatitis C: Consensus guidelines from the Canadian Association for the Study of the Liver RP Myers, A Ramji, M Bilodeau, S Wong, JJ Feld Canadian Journal of Gastroenterology and Hepatology 26 (6), 359-375, 2012 | 115 | 2012 |
| Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment S Cassim, VA Raymond, L Dehbidi-Assadzadeh, P Lapierre, M Bilodeau Cell cycle 17 (7), 903-916, 2018 | 94 | 2018 |
